Baxter Recalls Two Lots of IV SolutionsBy
Baxter International Inc. announced on December 18, 2015 that it is voluntarily recalling two lots of intravenous (IV) solutions to the hospital/end user level due to the potential presence of particulate matter. The particulate matter in each case was determined to be an insect and was identified as a result of a customer complaint. The matter was identified prior to patient administration and there have been no adverse events associated with this issue reported to Baxter to date.
The recall applies to two products: (1) 0.9% sodium chloride Injection, USP, 250-mL Viaflex Plastic Container, which is intended for IV use as a source of water and electrolytes and may also be used as a priming solution in hemodialysis procedures and (2) 70% dextrose injection (2000 mL) USP, which is indicated as a source of calories and water for hydration.
The lots being recalled were distributed to customers and distributors in the United States between June 6, 2015 and December 16, 2015.